Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roch Houot

Showing results (21-30 of 233) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 14, 2020
Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphomaRoch Houot, Philippe Armand, Caron A Jacobson
The Lancet. Haematology|August 28, 2020
Total immunotherapy for Hodgkin lymphomaRoch Houot, Reid W Merryman, Franck Morschhauser
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2015
Scientific Significance of Clinically Insignificant FcγRIIIa-V158F PolymorphismGuillaume Cartron, Roch Houot, Holbrook E Kohrt
European Journal of Cancer (Oxford, England : 1990)|October 19, 2016
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?Marie de Charette, Aurélien Marabelle, Roch Houot
European Journal of Cancer (Oxford, England : 1990)|October 18, 2023
Immune effector cell-associated acute stroke: A novel entity?Matteo Mauget, Sophie Lemercier, Roch Houot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2020
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?Roch Houot, Ronald Levy, Guillaume Cartron, et al.
Journal of Hematology & Oncology|April 20, 2021
CAR-T cells and BiTEs in solid tumors: challenges and perspectivesJulien Edeline, Roch Houot, Aurélien Marabelle, et al.
Cancer Metastasis Reviews|January 29, 2011
Immunomodulating antibodies and drugs for the treatment of hematological malignanciesRoch Houot, Holbrook Kohrt, Matthew J Goldstein, et al.
Leukemia|October 14, 2018
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cellsMarion Alcantara, Melania Tesio, Carl H June, et al.
Cancer Immunology Research|October 7, 2015
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint InhibitionRoch Houot, Liora Michal Schultz, Aurélien Marabelle, et al.
Pageof 24

Showing results (21-30 of 233) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|April 14, 2020
Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphomaRoch Houot, Philippe Armand, Caron A Jacobson
The Lancet. Haematology|August 28, 2020
Total immunotherapy for Hodgkin lymphomaRoch Houot, Reid W Merryman, Franck Morschhauser
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2015
Scientific Significance of Clinically Insignificant FcγRIIIa-V158F PolymorphismGuillaume Cartron, Roch Houot, Holbrook E Kohrt
European Journal of Cancer (Oxford, England : 1990)|October 19, 2016
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?Marie de Charette, Aurélien Marabelle, Roch Houot
European Journal of Cancer (Oxford, England : 1990)|October 18, 2023
Immune effector cell-associated acute stroke: A novel entity?Matteo Mauget, Sophie Lemercier, Roch Houot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 4, 2020
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?Roch Houot, Ronald Levy, Guillaume Cartron, et al.
Journal of Hematology & Oncology|April 20, 2021
CAR-T cells and BiTEs in solid tumors: challenges and perspectivesJulien Edeline, Roch Houot, Aurélien Marabelle, et al.
Cancer Metastasis Reviews|January 29, 2011
Immunomodulating antibodies and drugs for the treatment of hematological malignanciesRoch Houot, Holbrook Kohrt, Matthew J Goldstein, et al.
Leukemia|October 14, 2018
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cellsMarion Alcantara, Melania Tesio, Carl H June, et al.
Cancer Immunology Research|October 7, 2015
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint InhibitionRoch Houot, Liora Michal Schultz, Aurélien Marabelle, et al.
Pageof 24